Birx also joined the board of Innoviva this week, an investment firm in the Bay Area that collects royalties from certain lucrative GlaxoSmithKline medicines, according to a regulatory filing. She did not immediately respond to a request for comment.
Birx worked for many years in various parts of the federal bureaucracy for public health, including as general ambassador and global AIDS coordinator during the Obama administration.
But she gained national recognition under Trump, who appointed her to help coordinate the Covid response early in the pandemic. Birx played a central role in the first months of the effort and sometimes drew criticism from Democrats for her optimistic portrayal of the shaky federal response and the refusal to refute the impractical demands of former President Donald Trump.
Yet she eventually fell out of Trump’s favor as he campaigned for a speedy reopening of the country while the virus continued. She spent her last months on the task force to travel the country and urged the civil servants to hold rather focused on limiting the spread of the virus by enforcing public health restrictions.
Biden officials during the transition debated Birx’s retention to help with the ongoing response, but she announced in December that she wanted to resign from the government, citing the toll demanded by her family’s investigation last year. has.
In January, Birx said in an interview with CBS that she regularly considered terminating the Covid task force, and that they were dealing with “external advisers” who often offered Trump conflicting information about the pandemic.